Trial intelligence / Profile preview

Fentora for Breakthrough Pain in Neuropathic Pain

NCT00214955Phase 3Completed

Sponsor
Cephalon, Inc.
Start
Sep 2005
Primary completion
May 2006
Modality
Orthosteric Ligands
Countries
1
01

Overview

A Phase 3 trial of fentanyl in chronic neuropathic pain, sponsored by Cephalon, Inc.. Started Sep 2005; status: completed.

02

Drugs

fentanyl
03

Conditions

chronic neuropathic pain

Beyond the preview

Go deeper on NCT00214955.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NCT00214955.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call